This Nature News article reviews the rapid rise of single-cell technologies as powerful tools for immune profiling, highlighting how advances in sequencing and protein-based methods are allowing researchers to analyze individual immune cells with unprecedented depth and scale. It describes innovations such as mass cytometry and droplet-based RNA sequencing—approaches closely associated with work from the Shalek Lab—that enable scientists to map cellular diversity, trace developmental trajectories, and capture dynamic immune responses that are invisible in bulk measurements. The piece situates these technologies as transforming immunology by making it possible to study how heterogeneous cell populations coordinate during infection, inflammation, and disease, accelerating efforts to build more precise models of immune function and inform targeted therapeutic strategies.